224 related articles for article (PubMed ID: 3262687)
21. A substrate amplification system for enzyme-linked immunoassays. Demonstration of its general applicability to ELISA systems for detecting antibodies and immune complexes.
Carr RI; Mansour M; Sadi D; James H; Jones JV
J Immunol Methods; 1987 Apr; 98(2):201-8. PubMed ID: 3494782
[TBL] [Abstract][Full Text] [Related]
22. [Detection of circulating immune complexes by enzyme immunoassay. A basic study of C1q enzyme immunoassay and anti-C3 enzyme immunoassay using microplates].
Yokoyama K
Arerugi; 1984 Feb; 33(2):117-26. PubMed ID: 6380453
[No Abstract] [Full Text] [Related]
23. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
25. Presence of fucolipid antigens with mono- and dimeric X determinant (Lex) in the circulating immune complexes of patients with adenocarcinoma.
Singhal AK; Singhal MC; Nudelman E; Hakomori S; Balint JP; Grant CK; Snyder HW
Cancer Res; 1987 Nov; 47(21):5566-71. PubMed ID: 2444333
[TBL] [Abstract][Full Text] [Related]
26. C1q binding and C1q deviation assays using enzyme labelled C1q.
Smith GW; Myles MJ; Simpson IJ
J Immunol Methods; 1984 Feb; 67(1):167-72. PubMed ID: 6366065
[TBL] [Abstract][Full Text] [Related]
27. Measurement of serum antibodies to C1q and conglutinin in rabbits following feeding with cows' milk and in normal human serum.
Hanglow AC; Welsh CJ; Coombs RR
Adv Exp Med Biol; 1987; 216B():1317-23. PubMed ID: 3501233
[No Abstract] [Full Text] [Related]
28. Binding of aggregated human gamma globulin by Raji cells: C1q will enhance only if it is dissociated from the C1 macromolecular complex.
Manthei U; Strunk RC
Immunology; 1981 Jun; 43(2):287-92. PubMed ID: 6166545
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
Levinson SS; Goldman JO
J Clin Microbiol; 1987 Aug; 25(8):1567-9. PubMed ID: 2957387
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
Wines BD; Easterbrook-Smith SB
Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
[TBL] [Abstract][Full Text] [Related]
32. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
33. Measurement of circulating immune complexes in human sera by enzyme immunoassay.
Cheung K; O'Kane D; Robinson MF
Aust J Exp Biol Med Sci; 1982 Dec; 60(6):593-605. PubMed ID: 6820632
[TBL] [Abstract][Full Text] [Related]
34. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
35. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
36. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
Belozerov AP
Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
[TBL] [Abstract][Full Text] [Related]
37. The combined IGG, IGM and IGA peroxidase conjugate can facilitate determination of immune complexes by CIF-ELISA and anti-C3 ELISA.
Slavov E
Folia Med (Plovdiv); 1999; 41(1):149-52. PubMed ID: 10462947
[TBL] [Abstract][Full Text] [Related]
38. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
Bindon CI; Hale G; Brüggemann M; Waldmann H
J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
[TBL] [Abstract][Full Text] [Related]
39. Rat polymeric IgA binds C1q, but does not activate C1.
Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
[TBL] [Abstract][Full Text] [Related]
40. Failure of oligosaccharide MOPC-104E IgM complexes to bind C1q and to activate C1.
Weiner EM
Biochem Int; 1987 Jul; 15(1):163-8. PubMed ID: 3502595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
